MedTrace Logo

Herbal Treatment for Attention Deficit Hyperactivity Disorder (ADHD)

NCT00100295 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 59

Last updated 2007-10-26

No results posted yet for this study

Summary

The purpose of this study is to determine the safety and effectiveness of an herbal product for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents.

Conditions

  • Attention Deficit Hyperactivity Disorder

Interventions

DRUG

Hypericum perforatum

300 mg capsule taken three times a day

OTHER

Placebo

300 mg given three times a day, containing rice protein powder

Sponsors & Collaborators

  • National Center for Complementary and Integrative Health (NCCIH)

    lead NIH

Principal Investigators

  • Wendy Weber, ND, MPH · Bastyr University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-02-28
Completion
2006-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00100295 on ClinicalTrials.gov